Long-term administration of D-NAME induces hemodynamic and structural changes in the cardiovascular system

Physiological Research

Volumn 49, Issue 1, 2000, Pages 47-54

  Babal P ^a,b   Pechanova O ^c   Bernatova I ^c  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b Physics and Informatics   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Arterial hyperplasia; D NAME; Hypertension; L NAME; Myocardial fibrosis; Nitric oxide synthase

Indexed keywords

N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE FIBROSIS; HEMODYNAMIC PARAMETERS; HYPERTENSION; MALE; NONHUMAN; RAT;

ANIMALS; AORTA; CARDIOVASCULAR SYSTEM; DNA; ENZYME INHIBITORS; HEART VENTRICLES; HEMODYNAMIC PROCESSES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; STEREOISOMERISM;

EID: 0033963819     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. AMRANI M, ONSHEA J, ALLEN NJ, HARDING SE, JAYAKUMAR J, PEPPER JR, MONCADA S, YACOUB MH: Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J Physiol Lond 456: 681-687, 1992.
2. ARNAL JF, EL AMRANI AI, CHATELLIER G, MENARD J, MICHEL JB: Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22: 380-387, 1993.
3. BABÁL P, PECHÁŇOVÁ O, BERNÁTOVÁ I, ŠTVRTINA S: Chronic inhibition of NO synthesis produces myocardial fibrosis and arterial media hyperplasia. Histol Histopathol 12: 623-629, 1997.
4. BABÁL P, PECHÁŇOVÁ O, BERNÁTOVÁ I, ŠTVRTINA S: Cardiovascular morphologic changes in NO-deficient hypertension in rat. Physiol Res 48: 27P, 1999.
5. BERNÁTOVÁ I, PECHÁŇOVÁ O, ŠIMKO F: Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Physiol Res 45: 311-316, 1996.
6. BERNÁTOVÁ I, PECHÁŇOVÁ O, KRISTEK F: Mechanism of structural remodeling of the rat aorta during long-term L-NAME treatment. Jpn J Pharmacol 81: 99-106, 1999.
7. BREDT DS, SNYDER SH: Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990.
8. CHINELLATO A, FROLDI G, CAPARROTTA L, RAGAZZI E: Pharmacological characterization of endothelial cell nitric oxid synthase inhibitors in isolated rabbit aorta. Life Sci 62: 479-490, 1998.
9. DELACRETAZ E, HAYOZ D, OSTERHELD MC, GENTON CY, BRUNNER HR, WAEBER B: Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats. Hypertension 23: 967-970, 1994.
10. DEVLIN AM, BROSMAN MJ, GRAHAM D, MORTON JJ, MCPHADEN AR, MCINTYRE M, HAMILTON CA, REID JL, DOMINICZAK AF: Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. Am J Physiol 274: H52-H59, 1998.
11. G-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol 101: 10-12, 1990.
12. HOLÉCYOVÁ A, TÖRÖK J, BERNÁTOVÁ I, PECHÁŇOVÁ O: Restriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide deficient hypertension Physiol Res 45: 317-321, 1996.
13. KRISTEK F, GEROVÁ M: Long-term NO synthase inhibition affects heart weight and geometry of coronary and carotid arteries. Physiol Res 45: 361-366, 1996.
14. MOORE TM, KHIMENKO PL, WILSON PS, TAYLOR AE: Role of nitric oxide in lung ischemia and reperfusion injury. Am J Physiol 271: H1970-H1977, 1996.
15. MORENO H Jr, METZE K, BENUTO AC, ANTUNES E, ZATZ R, DE NUCCI G: Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res Cardiol 91: 248-255, 1996.
16. MORENO H Jr, NATHAN LP, METZE K, COSTA SK, ANTUNES E, HYSLOP S, ZATZ R, DI NUCCI G: Nonspecific inhibitors of nitric oxide synthase cause myocardial necrosis in the rat. Clin Exp Pharmacol Physiol 24: 349-352, 1997.
17. MOTZ W, PLOEGER M, RINGSWANDL G, GOELDER N, GARTHOFF B, KATZDA S, STRAUER BE: Influence of nifedipine on ventricular function and myocardial hypertrophy in spontaneously hypertensive rats J Cardiovasc Pharmacol 5: 55-61, 1983
18. NUMAGUCHI K, EGASHIRA K, TAKEMOTO M, KADOKAMI T, SHIMOKAWA H, SUEISHI K, TAKESHITA A Chronic inhibition of nitric oxide synthesis caused coronary microvascular remodeling in rats. Hypertension 26: 957-962, 1995.
19. PALMER RMJ, REES DD, ASHTON DS, MONCADA S: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 153: 1251-1256, 1988.
20. PECHÁŇOVÁ O, BERNÁTOVÁ I. Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues Physiol Res 45: 305-309, 1996.
21. PECHÁŇOVÁ O, BERNÁTOVÁ I, PELOUCH V, ŠIMKO F: Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol 29: 3365-3374, 1997.
22. PECHÁŇOVÁ O, BERNÁTOVÁ I, PELOUCH V, BABÁL P. L-NAME-induced protein remodeling and fibrosis in the rat heart. Physiol Res 48: 353-362, 1999.
23. PETERSON DA, PETERSON DC, ARCHER S, WEIR EK: The non-specificity of specific nitric oxide synthase inhibitors. Biochem Biophys Res Commun 187: 797-801, 1992.
24. REES DD, PALMER RMJ, SCHULTZ R, HODSON HF, MONCADA S: Characterization of three inhibitors of endothelial nitric oxide synthesis in vitro and in vivo. Br J Pharmacol 101: 746-752, 1990.
25. RIBEIRO NO, ANTUNES E, DE NUCCI G, LOVISOLO SM, ZATZ R: Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20: 298-303, 1992.
26. TAKEMOTO M, EGASHIRA K, USUI M, NUMAGUCHI K, TOMITA H, TSUTSUI H, SHIMOKAWA H, SUEIDHI K, TAKESHITA A: Important role of tissue angiotensin-converting enzyme in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 99: 278-287, 1997.
27. TÖRÖK J, GEROVÁ M: Vascular responses after long-term inhibition of nitric oxide synthesis in newborn dogs. Physiol Res 45: 323-328, 1996.
28. TURNER CH, OWAN I, JACOB DS, MCCLINTOCK R, PEACOCK M: Effects of nitric oxide synthase inhibitors on bone formation in rats. Bone 21: 487-490, 1997.
29. G-nitro-arginine in conscious rats are antagonized by L- but not D-arginine. Eur J Pharmacol 200: 77-81, 1991.
30. YAMADA K, NODA Y, NAKAYAMA S, KOMORI Y, SUGIHARA H, HASEGAWA T, NABESHIMA T: Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain Br J Pharmacol 115: 852-858, 1995.